Overexpression of cyclin D [20] and loss of Smad4 [21] contribute to ICC ability to escape from TGF-β growth inhibitory activity during the initial stages of tumorigenesis [20]. The gene discussed is TGFB1; the disease is intrahepatic cholangiocarcinoma.